ArticleFrontiers in immunology2025

Daratumumab combined with anti-CD20 therapy in pediatric and adult refractory idiopathic nephrotic syndrome: single-center experience.

Hamza Naciri Bennani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.